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This paper explores the possible relationships between dietary fructose and altered neurohumoral regulation of renal
haemodynamic and excretory function in this model of metabolic syndrome. Fructose consumption induces hyperinsulinemia,
hypertriglyceridaemia, insulin resistance, and hypertension. The pathogenesis of fructose-induced hypertension is dubious
and involves numerous pathways acting both singly and together. In addition, hyperinsulinemia and hypertension contribute
signiﬁcantlytoprogressiverenaldiseaseinfructose-fedrats.Moreover,increasedactivityoftherenin-angiotensinandsympathetic
nervous systems leading to downregulation of receptors may be responsible for the blunted vascular sensitivity to angiotensin
II and catecholamines, respectively. Various approaches have been suggested to prevent the development of fructose-induced
hypertension and/or metabolic alteration. In this paper, we address the role played by the renin-angiotensin and sympathetic
nervous systems in the haemodynamic alterations that occur due to prolonged consumption of fructose.
1.Fructose-Feedingas aModelof
MetabolicSyndrome
Metabolic syndrome or “syndrome X” is a cluster of patholo-
gies comprising insulin resistance, hyperinsulinemia, hyper-
triglyceridemia, accelerated atherosclerosis, and hyperten-
sion [1, 2] and is associated with morbidities such as
increased risk of developing cardiovascular disease, Type 2
diabetes mellitus, and renal disease [3–7]. Previous studies
have shown that the fructose-fed rat model develops an
insulin-resistance syndrome with a very similar metabolic
proﬁle to the human condition, including hyperinsulinemia,
insulin resistance, hypertriglyceridemia, and decreased HDL
cholesterol [8, 9]. Consequently, the administration of a
fructose-rich diet has been used as a model for investigating
the development of the metabolic syndrome [10]. Variable
amounts of fructose and modes of intake have been utilized
which have resultedin the expression of a range of featuresof
the metabolic syndrome. S´ anchez-Lozada et al. [11] admin-
istrated fructose either in the drinking water or as a dietary
component and induced hypertension, hyperuricemia, and
hypertriglyceridemia [11]. However, fructose in the feed was
found to result in a more severe metabolic syndrome and
kidney damage compared to fructose given in the drinking
water which suggested a relationship between the amount
of fructose consumed and the development of deleterious
eﬀects [11]. This was supported by a previous study in
the rat which proposed that fructose-induced hypertension
was concentration and time dependent [12]. It is evident
from these reports that the fructose model can be a useful
tool for studying various aspects of metabolic syndrome
by manipulating routes, amounts, and lengths of exposure
to fructose which may have applicability to the human
situation as the metabolic syndrome develops. Table 1 shows
the various routes of fructose administration and diﬀerent
feeding periods.
2.Fructose Consumption andEnergy Intake
Fructose is a natural sugar found in many fruits and honey
and is commonly used as a sweetener. Because high dietary2 International Journal of Nephrology
Table 1: The eﬀe c to fd i ﬀerent routes of fructose administration in diﬀerent species over diﬀerent time periods.
Method of
administration Species Amount∗ Length of study Eﬀect Reference
Drinking Mouse 10% 3 weeks -Hypertension, hyperinsulinemia [13]
Rat 10% 8 weeks -Hypertension, hypertriglyceridemia [11]
5 weeks -Hypertension, insulin resistance [14]
6–19 days -Hypertriglyceridemia [15]
20% 8w e e k s
30 days
-Hypertension, hyperglycemia,
hyperinsulinemia [16]
-Impaired glucose tolerance, dyslipidemia [17]
60% 2 weeks Hyperglycemia [18]
Hamster 10%, 20% 2, 4 and 6 months Hyperglycemia, hyperinsulinemia [19]
guinea pigs 10% 6–19 days Hypertriglyceridemia [15]
10% 18 weeks Hyperglycemia [20]
Food Mouse 60% 8 weeks -Hypertension, impaired glucose tolerance,
dyslipidemia [21]
Rat 60% 8 weeks -Hypertension, hypertriglyceridemia [11]
6 weeks -Hyperinsulinemia, hypertriglyceridemia [22]
66% 4 weeks -Hyperinsulinemia [23]
2w e e k s -Hypertension, hyperinsulinemia,
hypertriglyceridemia [24]
4 weeks -Hyperglycemia [18]
Hamster 60% 2 weeks -Hyperinsulinemia, hypertriglyceridemia [25]
Dog 60% 20–28 days -Hypertension, insulin resistance,
hyperinsulinemia, hypertriglyceridemia [26]
Human 15% 5 weeks -Hyperinsulinemia, hyperglycemia [27]
20% 5 weeks -Hypertriglyceridemia [28]
∗Percentage is (weight/volume) for drinking form and (weight/weight) for food form.
fructose intake does not result in a signiﬁcant weight gain,
the fructose-fed rat model can be used to investigate the
relationship between metabolic alterations and the develop-
ment of hypertension without the confounding inﬂuences
of obesity or genetic predispositions. Although the absence
body weight gain has been reported in a considerable
number of studies in rats [24, 29–34]a n dd o g s[ 26],
there have been reports of weight gain in rodents [12, 16,
35–37] and in human [38, 39]. One possible reason for
these conﬂicting ﬁndings is that fructose was introduced
at diﬀerent stages of maturity and with diﬀerent eﬀects on
weight gain. This is supported by the view that in this model,
the younger animals gain more weight than the older ones
[40]. Moreover, fructose through its suppression of leptin, a
hormone that produces the sensation of satiety [41], could
induce an increase in caloric intake and thereby weight gain.
However, there are reports that fructose feeding increases
fasting plasma level of leptins in rats [42–45] and in humans
[46], or even produced no change [47]. An increase in
plasma levels of leptin could be taken to indicate resistance
to its action [48], and interestingly leptin resistance has been
reported in rats even though plasma leptin levels may be
unchanged [47]. This change in energy metabolism has been
linked to hypertriglyceridemia in this model [42, 49, 50]. It is
therefore evident that, whatever the underlying mechanism,
a direct relationship exists between high dietary fructose
intake and increased weight gain associated with higher
energy consumption in this model.
3. Fructose Consumption and
InsulinResistance
Insulin stimulates glucose uptake, increases glycogen syn-
thesis, and decreases gluconeogenesis and if the hormone is
unable to elicit these actions, insulin resistance is said to exist
and results in increased plasma insulin levels [51–53]. The
hyperinsulinemia associated with insulin resistance has been
found in fructose-fed rat [16, 54–57] and has been linked to
hypertension development in this model [1, 58, 59]. Hepatic
insulin resistance has also been reported following fructose
consumption in humans [60]. One possible explanation for
insulin resistance in fructose-fed rats is a downregulation
of insulin receptors with lower insulin receptor mRNA
levels in skeletal muscle but not kidney. This eﬀect has
been found to be associated with a decreased insulin-
stimulated glucose utilization and a reduction in insulin
sensitivity [61]. Nakagawa et al. [62] reported that fructose
feeding for 10 weeks not only induced hyperinsulinemia
and hypertriglyceridemia but also hyperuricemia in rats.
Interestingly, fructose has the property of inducing high
plasma levels of uric acid [63]. This eﬀect was reportedInternational Journal of Nephrology 3
to be a result of fructose metabolism, in that it undergoes
phosphorylation by the enzyme fructokinase (also called
ketohexokinase) into fructose-1-phosphate using ATP as a
phosphate donor. However, unlike glucokinase and phos-
phofructokinase, which are involved in glucose metabolism,
fructokinase lacks the negative feedback mechanism that
prevents its action. The end result is in an accumulation
of the phosphorylated substrate and therefore depletion of
hepatic ATP with a consequent increase in the degradation
of nucleotides to uric acid [64]. Furthermore, the insulin
resistance induced by fructose intake appears to be mediated
by the elevated uric acid levels [62, 65]. It would seem
that uric acid inhibits endothelial function by impairing
nitric oxide (NO) induced vasodilation which is necessary
for insulin to stimulate glucose uptake into the tissues. This
eﬀect of uric acid on endothelial function has also been
reported in the human [66]. It has been widely reported
that treating fructose-fed rats with uric acid lowering agents
(Table 2) decreased plasma insulin levels, enhanced insulin
sensitivity, and decreased blood pressure [62, 67]. There is
general agreement that insulin resistance/hyperinsulinemia
are the most important features of metabolic syndrome
and indeed, metabolic syndrome sometimes is referred to
as a state of insulin resistance. This may be due to the
association of insulin resistance with other manifestations of
the metabolic syndrome especially hypertension. However, it
may be that other features yet unidentiﬁed are also impor-
tant.
4. Fructose Consumption andHypertension
Hwang et al. [24] initially reported that hypertension could
be induced by feeding a fructose-rich diet, and this was sup-
ported by subsequent studies demonstrating a link between
dietary fructose intake and elevation in blood pressure [12,
16, 24, 67]. The fructose-induced elevation in blood pressure
was found concomitantly to produce insulin resistance,
hyperinsulinemia [59, 92], and hypertriglyceridemia [93].
Insulin resistance and compensatory hyperinsulinemia may
act as predisposing factors for the development of hyper-
tension possibly through activation of the sympathetic ner-
vous system (SNS) [94]. This relationship between insulin
resistance and hypertension has been reported in rodents
[59, 95, 96]a sw e l la sh u m a n[ 97, 98] and interventions that
prevented insulin resistance in this model also normalized
bloodpressure[33,57,59,76,99].Thereisanindicationthat
this action of fructose is time and concentration dependent
with one week or longer of 10% fructose in drinking water
(equivalent to a diet containing 48–57% fructose) being
suﬃcient to induce an elevation in blood pressure in the
rat [12] .I n s u l i nh a sb e e nf o u n dt oc h r o n i c a l l ya c t i v a t e
the sympathetic nervous system and cause an increased
peripheral vascular tone leading to an elevation in blood
pressure. A consequence is that activation of the sympathetic
nervous system may contribute to insulin resistance by
causing a vasoconstriction that leads to a decreased blood
ﬂow and therefore decreased delivery of glucose to the
tissues [100–102]. Another possibility is that renal sodium
reabsorption induced by the increased sympathetic activity
[103], arising from the insulin resistance, contributes to the
development of hypertension. It is therefore evident from
all these studies that a causal relationship between insulin
resistance/hyperinsulinemia and hypertension exists in the
fructose-rich diet model, with the sympathetic nervous
system potentially playing an important role in both the de-
velopment of hypertension and insulin resistance.
5. Mechanismof Fructose-Induced
Hypertension
Although a number of studies have linked fructose feeding
with hypertension [8, 16, 24, 33, 104, 105], there are
other reports that have not observed an increased blood
pressure in this model [32, 71, 106, 107]. This conﬂict has
been attributed to either dietary composition [108, 109],
diﬀerences in animal age or strain [71], or the diﬀerent
techniques used to measure blood pressure [32, 107, 110].
There is uncertainty regarding the exact mechanisms by
which fructose consumption produces an increased blood
pressure, but several possibilities have been proposed (Fig-
ure 1) including increased sympathetic nervous system
activity [21, 72, 111], elevated circulating catecholamines
[112], enhanced renin-angiotensin system activity and Ang
II levels [112, 113], increased sodium reabsorption [114],
impaired endothelium-dependent relaxation [9, 115, 116],
and increased secretion of endothelin-1 (ET-1) [92, 117,
118]. All of these factors may contribute to an increased
vascular tone and impaired endothelial function. Further-
more, there is evidence that hyperinsulinemia itself causes
hypertension as long-term insulin administration causes an
increased blood pressure in rats [96, 119]w h i c hi sr e v e r s e d
upon discontinuation of the insulin [120]. A further sugges-
tion has been that Na+/H+ exchanger activity is increased
in association with hyperinsulinemia following chronic
fructoseintake[121].Inaddition,Catenaandcoworkers[61]
have shown the antinatriuretic eﬀect of hyperinsulinemia is
determined by a mechanism that depends on the number of
insulin receptors in the tissues, and this density is inversely
related to dietary salt intake. Therefore, under conditions of
long-term high salt intake together with elevated fructose
feeding, the control mechanism for sodium balance will be
deranged [61]. The combined eﬀect of fructose and salt
has been further investigated, and long-term vascular eﬀects
contributing to hypertension have been reported [122]. A
raised dietary fructose intake can also enhance the absorp-
tion of sodium chloride from the gastro-intestinal tract by
increasingtheactivityoftheGlut5(Slc2a5)transporterinthe
gut [123]. Furthermore, a recent study in mice showed that
theGlut5transporterwasresponsibleforfructoseabsorption
from the intestine and its enhanced activity could contribute
to the development of hypertension [124]. Thus far, many
studies have investigated various mechanisms that may be
responsible for the development of high blood pressure due
tofructoseconsumptionbutwhetherbloodpressurechanges
signiﬁcantly in this model remains under debate.4 International Journal of Nephrology
Table 2: The eﬀect of various interventions on fructose-induced hypertension and insulin resistance in rat.
Amount fed Length of
study Intervention Length of
intervention Eﬀect Reference
66% fructose in diet 2 weeks Exercise training 2 weeks
↓ plasma insulin,
↑ insulin sensitivity,
↓ blood pressure
[68]
66% fructose in diet 11 days Somatostatin 7 days
↓ plasma insulin,
↓ blood pressure [69]
66% fructose in diet 6 weeks Vinadyl sulfate 6 weeks
↑ insulin sensitivity,
↓ blood pressure [70]
Thiazolidinediones:
66% fructose in diet 4 weeks pioglitazone 4 weeks
↑ insulin sensitivity,
↓ blood pressure [71]
Sympathetic nervous system inhibitors:
66% fructose in diet 11 weeks chemical sympathectomy
rilmenidine
10 weeks ↓ plasma insulin, [72]
34.5% fructose in diet 4 weeks 2 weeks ↓ blood pressure [73]
Renin-angiotensin system inhibitors:
60% fructose in diet
5 weeks enalapril 2 weeks ↓ plasma insulin, [74]
5w e e k s telmisartan (PPARγ agonist
eﬀect) 2w e e k s ↓ blood pressure [75]
4 weeks losartan 4 weeks [76]
10% fructose in
drinking water 8w e e k s 8w e e k s [ 77]
40% fructose in diet 2 weeks quinapril 2 weeks
↑ insulin sensitivity,
↓ blood pressure [78]
Calcium channel blockers:
60% fructose in diet 6 weeks clonidine 2 weeks ↑ insulin sensitivity, [79]
10% fructose in
drinking water 38 weeks felodipin 6 weeks ↓ blood pressure [80]
Superoxide dismutase mimetics:
60% fructose in diet 4 weeks tempol 4 weeks ↓ blood pressure [81]
NAD(P)H oxidase inhibitors:
60% fructose in diet 8 weeks apocynin 8 weeks ↓ blood pressure [82]
α-Adrenergic agonist:
66% fructose in diet 17 days clonidine 14 days ↓ blood pressure [24]
Endothelin receptors antagonists:
60% fructose in diet 8 weeks enrasentan 4 weeks ↓ blood pressure [83]
Antioxidants:
56.8% fructose in diet 6 weeks vitamin E 6 weeks ↑ insulin sensitivity, [84]
60% fructose in diet 12 weeks N-acetylcysteine 12 weeks ↓ blood pressure [85]
Xanthine oxidase inhibitors:
60% fructose in diet 8w e e k s f e b u x o s t a t 4w e e k s ↓ plasma insulin,
↑ insulin sensitivity,
↓ blood pressure
[67]
10 weeks allopurinol 6 weeks [62]
Thromboxane synthase inhibitors:
60% fructose in diet 7 weeks dazmegrel 7 weeks ↓ blood pressure [86]
Lipid-lowering agents:
66% fructose in diet 6 weeks rosuvastatin 5 weeks ↓ plasma insulin [87]
Sex hormones:
66% fructose in diet 10 weeks gonadectomy 6 weeks
↓ blood pressure
[88]
60% fructose in diet 9w e e k s 9w e e k s [ 89]
6-7 weeks estrogen 6-7 weeks [90]
Gene therapy:
10% fructose in
drinking water 5w e e k s human tissue kallikrein
cDNA 3w e e k s
↓ plasma insulin,
↓ blood pressure [91]
↑ indicates increase; ↓ indicates decrease.International Journal of Nephrology 5
Fructose
↓ BRA Dyslipidemia Oxidative stress ↑ Uric acid
Insulin resistance
Hyperinsulinemia
↑ SNS
↑ RAS ↑ Vasoconstriction
↑ Na+ retention Endothelial
dysfunction
Hypertension
Figure 1: The proposed mechanisms by which fructose feeding
results in hypertension. BRA: baroreﬂex sensitivity; SNS: sympa-
thetic nervous system; RAS: renin-angiotensin system.
6. Fructose Consumption and
VascularDysfunction
The vascular system is important for the delivery of nutri-
ents and hormones to the tissues and consequently any
impairment in vascular responsiveness may contribute to
insulin resistance [51, 52, 100]. On the other hand, insulin
resistance and hyperinsulinemia in fructose-fed rats impair
endothelial function and thereby contribute to the elevated
blood pressureinthismodel [125]. Vasculardysfunction due
toafructose-richdiethasbeenreportedintherat[116,126],
and it is recognized that vascular dysfunction in metabolic
syndrome is associated with increased vasoconstrictor sen-
sitivity [127] and production of vascular superoxide anions
[128–130]. In addition, impaired endothelium-dependent
relaxation has been found to occur after chronic fructose
intake in mice [131] and rats [116, 118, 128, 132, 133].
There is now evidence that insulin modulates the expression
of endothelial nitric oxide synthase enzyme (eNOS) and
stimulates nitric oxide (NO) production causing vasodila-
tion [134, 135]. However, in states of insulin resistance, the
eﬀects on eNOS and NO were blunted resulting in impaired
endothelium-dependent relaxation [126, 136, 137]. Thus, it
is possible that this blunted vascular action of insulin in itself
can contribute to and exacerbate the development of insulin
resistance [51, 52, 101]. Furthermore, there is evidence
in mesenteric vessels that long-term fructose-feeding is
associated with an impairment of α2-adrenergic-mediated
relaxation which is dependent on NO. In other studies using
aortae of fructose-fed rats, endothelium-dependent relax-
ation was decreased [138]. Thus, an impaired endothelial-
dependent vasodilatory mechanism may also be involved in
the development of hypertension in this model [125]. From
all these ﬁndings, it is apparent that endothelial dysfunction
in metabolic syndrome is related to the presence of insulin
resistance/hyperinsulinemia which results not only in an
enhanced vascular tone but also in blunted vasodilatory
mechanisms.
7. Fructose Consumption andOxidativeStress
Fructose-feeding in rats has been found to increase oxidative
stress as reﬂected by the generation of reactive oxygen
species that play a key role in the cardiovascular abnor-
malities associated with insulin resistance [130]. There is
evidence that treatment with antioxidants, such as vitamin
E, improves insulin resistance in fructose-fed rats [84], while
the oxidative damage brought about by dietary fructose is
due to a defect in the antioxidant defense mechanism and
increased free radical production [139]. There is an elevation
in lipid peroxidation when assessed by the increased plasma
levels of malonyldialdehyde (MDA) and decreased plasma
glutathione (GSH) [84, 130, 140, 141]. Excess superoxide
radical (O2
−) is produced in the vasculature of rats with
insulinresistancewhichinturncandegradeNOandenhance
the generation of other reactive oxygen species which are
responsible for lipid peroxidation and therefore vascular
damage [128, 133]. Based on these ﬁndings, it has been
suggested that taurine, a sulphur-containing amino acid, is
capable of decreasing oxidative stress and improving insulin
sensitivity in fructose-fed rats [142, 143]. This amino acid
is a derivative of the sulfur-containing amino acid cysteine,
which is the precursor of GSH and has been reported to be
availableinexcitabletissuesandcells.Furthermore,Korandji
et al. [138] have reported that the level of asymmetric
dimethylarginine (ADMA), an endogenous modulator of
endothelial function and oxidative stress, is high in fructose-
fed rats. This increase in ADMA is possibly due to the
increased oxidative stress and associated hypertension in this
model. Therefore, oxidative stress due to fructose-feeding is
associated with higher levels of lipid peroxides and other
reactive substances in the presence of a defective antioxidant
system.
8. Effect of Fructose Feeding on Adrenergic and
Ang II Control of Renal Vascular Tone
The eﬀects of fructose-induced metabolic syndrome on
the functional contribution of α1-adrenoceptor-mediated
vasoconstriction of resistance vessels have not been fully
elucidated, and there is conﬂicting data regarding whether
it is associated with an enhancement [145] or inhibition
[16, 131] of adrenergically induced renal vasoconstric-
tions. Fructose feeding attenuated the vascular contractile
responses to noradrenaline in vitro which was mainly due
to higher GTP-binding protein activity which is coupled
to α2-adrenoceptors on the vascular endothelium [131]. A6 International Journal of Nephrology
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Figure 2: (a) The eﬀect of fructose-feeding on the renal vascular responses to adrenergic agonists and Ang II. The vascular responses, as
assessed by the reduction in renal cortical blood ﬂow (CBF) due to adrenergic agonists or Ang II intra-arterial administration (see methods),
were signiﬁcantly lower in fructose-fed (the gray square) compared to control (the white square) animals. (b) The eﬀect of streptozotocin-
induced diabetes on the renal vascular responses to adrenergic agonists and renal nerve stimulation. The vascular response to adrenergic
stimuli as assessed by reduction in total renal blood ﬂow (RBF) due to renal vasoconstriction was slightly lower although signiﬁcant only
for noradrenaline in diabetic (the gray square) compared to nondiabetic (the white square) rats. Figures are reproduced from Abdulla et al.
[16] and Armenia et al. [144] respectively. Data, mean ± SEM represent the overall mean of responses to a range of doses from each agonist.
Statistical analysis was performed by unpaired t-test for comparing between two groups each time, ∗ is P< 0.05 of fructose-fed versus
control in (a) or diabetic versus nondiabetic in (b), (n = 6). NA: Noradrenaline; PE: phenylephrine; ME: methoxamine; RNS: renal nerve
stimulation.
reduction in the vascular sensitivity to catecholamines due
to receptor desensitization has been proposed as a compen-
satory mechanism resulting from increased sympathetic
nervous system activity [146, 147]. In support of this notion,
studies from our laboratory have shown that adrenergic-
andAngII-mediatedrenalvasoconstrictionswereattenuated
in fructose-fed rats [16] (Figure 2(a)). In addition, using
another model of metabolic syndrome, we reported that
the streptozotocin-induced diabetic rats had attenuated
responses to adrenergic stimulation [144] (Figure 2(b)). One
explanation for the reported blunted renal vasoconstrictor
responses to Ang II and adrenergic agonists is the higher
circulating levels of Ang II and noradrenaline and raised
urinary excretion of noradrenaline in fructose-fed rats [112,
113]. Impaired vascular responses to exogenously adminis-
tered noradrenaline, but not Ang II, have been reported in
fructose-fed rats both in vivo and in vitro.T h es u g g e s t i o n
has been made that the vasculature may have adapted to the
increased sympathetic activity present in this model [148].
It is acknowledged that an increased sympathetic nervous
system activity could blunt the responses to exogenously
administered noradrenaline as a consequence of downregu-
lation of adrenoceptors [146]. Another explanation for the
attenuated adrenergic responses may be a compensatory
mechanism to induce structural or functional changes that
precede hypertension in the vasculature of diet-induced
hypertension model as previously mentioned [148]. The
ability of insulin to hyperpolarize vascular smooth cells
through the activation of the Na+,K +-ATPase pump, thereby
decreasing Ca2+ inﬂux via voltage-operated channels, may
also underlie the blunted vascular responses to exogenously
administered noradrenaline [149, 150]. Indeed, Khan et
al. [150] have reported that insulin inhibits extracellular
K+- and agonist-induced contractions of vascular smooth
muscle cells and attenuates the intracellular Ca2+ transient in
agonist-stimulated cells. However, in the rats that naturally
developinsulinresistance,thesensitivityofα1-adrenoceptor-
mediated arteriolar vasoconstriction was increased after
the onset of insulin resistance [151]. Furthermore, in the
fructose-induced insulin resistance condition, there is a
pronounced vascular dysfunction associated with increased
vasoconstrictor sensitivity [127], as insulin is well known
to exert multiple eﬀects on vascular tone. In humans,
insulin was shown to increase the cardiovascular response
to noradrenaline but not to Ang II [152], but, it has also
been reported that intra-arterial insulin infusion attenuates
vascular reactivity to phenylephrine and Ang II [153]. In
addition, in vitro studies revealed that insulin attenuated
noradrenaline and Ang II induced vasoconstriction in the
rabbit femoral artery [154]a n dr a tt a i la r t e r y[ 155]. In
a prediabetic obesity model, Stepp et al. [156]r e p o r t e d
increased renal vasoconstrictor sensitivity to Ang II in
Zucker rats although this was possibly secondary to an
impaired baroreﬂex mechanism due to altered sympathetic
modulation of vascular resistance in this model [157].
However, in this same study, there was no change in the
renal vasoconstrictor response to Ang II due to fructose-
feeding which indicated that insulin resistance may not be
a cause of the impaired renal vascular responses to Ang
II. The insulin-resistant state due to fructose feeding hasInternational Journal of Nephrology 7
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Figure 3: Proposed mechanisms that may explain the decreased
vascularresponsestovasoactivecompoundsinthefructose-fedrats.
↑ and ↓ stand for increase and decrease, respectively.
also been associated with enhanced contractile responses
to Ang II with AT1 receptor upregulation and increased
endothelial O2
− production caused by an activation of
NAD(P)H oxidase [127]. Interestingly, treatment with an
AT1 receptor blocker resulted in an inhibition of NAD(P)H
oxidase and the Ang II-induced vasoconstriction, in addition
to amelioration of endothelial dysfunction in this fructose-
fed model.
The data regarding the eﬀect of fructose-feeding on the
functional contribution of α1-adrenoceptors subtypes in the
renal vasculature is scarce. The only available reports are
those arising from our own laboratory which have demon-
strated that α1B-adrenoceptors make a lower contribution
to renal vascular tone in fructose-fed rats [16]. This may
provide further support for the notion that α1A- and/or
α1D-adrenoceptors are major contributors in mediating the
renal vasoconstriction induced by adrenergic stimuli in
rats during hypertension. From the available reports, it is
clear that the eﬀects of fructose-feeding on the vascular
response to adrenergic activation are not well investigated
and need further exploration. Figure 3 presents some of
the proposed mechanisms that may explain the decreased
vascular responses to vasoactive compounds in fructose-fed
rats.
9.Fructose Consumption andthe Sympathetic
Nervous System
Insulin has been acknowledged as playing key roles in a
variety of important biological functions, one of which
is an activation of the sympathetic nervous system. This
sympatho-excitatory eﬀect of insulin may be mediated by a
baroreﬂex mechanism [158] or by a direct eﬀect of insulin
on noradrenaline release from sympathetic nerve endings
[159, 160]. These eﬀects may possibly explain the link
between hyperinsulinemia and high blood pressure [159].
As insulin activates the sympathetic nervous system, there
will be an increased peripheral vascular tone which in turn
will elevate blood pressure. In support of this concept,
insulin infusion was found to elevate plasma noradrenaline
and blood pressure levels in normal individuals [161]a n d
to increase cardiac sympathetic activity in type 2 diabetic
patients [162]. Moreover, in obese subjects, the correction of
hyperinsulinemia decreased both circulating noradrenaline
levels and blood pressure [163]. This relationship received
direct support from the observation in normal humans
that hyperinsulinemia increased noradrenaline release from
forearmmusclewhichwasmorepronouncedinpatientswith
essential hypertension [164].
The exact function of insulin and its receptors within
the central nervous system (CNS) has been uncertain until
recently.Inadditiontoitsregulatoryeﬀectonenergystorage,
insulin plays a key modulatory role in aﬀerent (and eﬀerent)
hypothalamic pathways governing energy intake [165]. It
has been shown that antagonism of insulin signaling in
the brain can impair the ability of circulating insulin to
inhibit glucose production [166]. On the other hand, there
is evidence that increased sympathetic activity results in
insulin resistance due to α1-adrenoceptor activation causing
a reduction in blood ﬂow and therefore a reduction in
glucose delivery to skeletal muscle [100, 159]. The out-
come, then, is a continuous stimulation of sympathetic
nervous system due to compensatory hyperinsulinemia in
response to the insulin resistance. This view has been
supported by studies demonstrating that blockade of the
sympathetic nervous system, by chemical sympathectomy
[72] or decreasing sympathetic outﬂow [73, 111], prevented
boththedevelopmentofhyperinsulinemiaandhypertension
in fructose-fed rats (Table 2). This would imply that the
developmentofhyperinsulinemiaandhighbloodpressurein
this model depends on an intact sympathetic nervous system
[72].Theseﬁndings, togetherwithpoints discussedearlierin
this paper, are in agreement regarding the key role played by
this system in the metabolic syndrome.
10. Effect of Fructose Feeding on Baroreﬂex
Control of the Sympathetic Nervous System
It becomes evident now that the metabolic syndrome is
associated with higher sympathetic nerve activity which is
modulated by insulin resistance as well as alterations in
reﬂex regulatory mechanisms [167]. The baroreﬂex control
of arterial blood pressure is considered key to cardiovascular
homeostasis but there is controversy regarding its long-term
control of sympathetic activity and arterial pressure. There
is a consensus that the baroreﬂex mechanism is important
in the short-term regulation of heart rate, sympathetic tone,
and consequently blood pressure. However, it is becoming
recognised that pressure-induced increases in baroreﬂex
activity persist for longer periods of time than previ-
ously reported. Impairment of baroreﬂex sensitivity in the8 International Journal of Nephrology
metabolic syndrome involves both the sympatho-inhibitory
andthesympatho-excitatorybaroreﬂexcomponents[168]as
well as impairment of the cardiopulmonary mechano- and
chemo-receptors [169]. Baroreﬂex sensitivity derived from
measuring blood pressure has been utilized as a parameter
to assess cardiovascular autonomic balance which is altered
in hypertension [170–172]. In addition to cardiovascular
disease, impaired baroreﬂex sensitivity is associated with the
metabolic syndrome. In individuals with insulin resistance,
the baroreﬂex sensitivity was found to be signiﬁcantly lower
compared to their healthy counterparts [173]w i t hh y p e r -
tension. It appeared that obesity and hypertriglyceridemia
may be the main contributory factors associated with the
impaired baroreﬂex sensitivity during metabolic syndrome
[174].Moreover,Zieglerandothershavereportedabnormal-
ities of baroreﬂex sensitivity in relation to the cardiovascular
system in diabetes mellitus in humans [175, 176]a n dr a t s
[177,178].Impairmentinbaroreﬂexsensitivityhasalsobeen
reportedinstreptozotocin-induced diabeticratsfedonhigh-
fat emulsion for 30 days [179]. There has been a suggestion
that the higher circulating levels of vasopressin and Ang
II in diabetic humans and rats play a role in this altered
baroreﬂex function [180, 181]. However, inhibition of the
renin-angiotensin system with the angiotensin converting
enzyme inhibitor, enalapril, was not associated with any
alteration in baroreﬂex-mediated renal sympatho-inhibition
in diabetic rats [182]. A further suggestion has been that
lipid abnormalities which arise in the metabolic syndrome
areassociatedwithimpairedbaroreﬂexsensitivity.Therefore,
diets known to improve the lipid proﬁle, such as a diet high
in monounsaturated fatty acids, have been found to improve
baroreﬂex sensitivity in subjects with metabolic syndrome.
This provides evidence that the baroreﬂex mechanism is
particularly sensitive and inﬂuenced by changes in diet-fat
intake[183].Aietal.[179]haveshownthatthehighpressure
baroreﬂex sensitivity is impaired in Wistar rats fed a high-
fat and carbohydrate diet in which fructose and sucrose
are included as a diet component. However, a study by
Wong and Johns [18] reported an impairment in the reﬂex
eﬀerent renal sympatho-inhibition to volume expansion in
the diet-induced obese rats but not in the fructose-fed rats.
This may possibly be attributed to the diﬀerent sympathetic
mechanisms and abnormalities responsible for the develop-
ment of high blood pressure in fructose-fed rat compared
to diet-induced obese rat. Other studies have also reported
an attenuation of the baroreﬂex compensatory mechanism
in insulin-resistant Zucker obese rats [157]. Based on the
notion that sympathetic hyperactivity is present in the
fructose-rich diet model of insulin resistance, inhibition of
the sympathetic nervous system would be a signiﬁcant target
for drug treatment (Table 2).
11. Fructose Consumption andRenal
SodiumHandling
A possible mechanism by which hyperinsulinemia could
lead to hypertension is excessive sodium retention due to
increased renal tubular sodium reabsorption [184]. During
insulin resistance, the vasodilator eﬀect of insulin may be
blunted and hence becomes unable to oﬀset the counter-
regulatory fall in proximal tubular sodium reabsorption dur-
ing hyperinsulinemia and thus predispose to sodium reten-
tion [185]. Furthermore, acute administration of insulin
results in decreased excretion of sodium in animals [186,
187] and humans [184, 188]. It has been reported that
insulin-induced hypertension is associated with a shift in
pressure natriuresis with the impairment in renal sodium
excretion and seems to occur chronically during insulin
infusion [96, 189, 190]. Albeit that studies have shown
the reduction in sodium excretion after the long-term
consumption of fructose-rich diet [81, 191], other studies
have reported no change in sodium excretion [76, 156]
(Table 3). Interestingly, Iyer and Katovich [192] have shown
that fructose feeding for 6 weeks does not cause any change
in sodium excretion, and they have suggested that sodium
retention may not be the cause of high blood pressure in this
model. At an intrarenal level, urinary sodium excretion and
renal interstitial hydrostatic pressure have been suggested
to be under the inﬂuence of the NO system [193, 194],
and any defect in NO generation may result in salt-sensitive
hypertension [195–197]. Thus, the issue arises as whether
there is the development of salt-sensitive hypertension in an
insulin-resistant state when there is impairment of the renal
NO system. In addition, eNOS has been reported to play
an important role in sodium handling [198] and has been
demonstrated to be decreased in the kidneys of fructose-fed
and salt-sensitive fructose-fed hypertensive rats [108, 126].
As yet, the mechanism by which fructose-feeding results in
raised sodium reabsorption which may contribute to the
initiation of hypertension remains to be determined.
12. Fructose Consumption and Progressionof
Renal Disease
There is controversy regarding the causal relationship be-
tween fructose-feeding and the incidence of chronic kidney
disease. However, several studies have reported that fruc-tose
intake is associated with hyperuricaemia [63, 200, 205, 206],
albuminuria [199, 200, 207], and progression into kidney
disease [207]. Others have shown that fructose feeding
for 2 weeks resulted in hyperﬁltration and hyperplasia of
mesangialcellsinglomeruli[204].S´ anchez-Lozadaetal.[11]
reported that high fructose intake in addition to inducing
the metabolic syndrome can result in the development
of kidney hypertrophy, glomerular hypertension, cortical
vasoconstriction, and arteriolopathy. Moreover, fructose
consumption was found to accelerate the progression of
chronic renal disease in rats [22] and has been reported to
induce glomerular hypertension and sclerosis of the aﬀerent
arteriole [11]. Cirillo et al. [208] have interestingly shown
that postprandial concentrations of fructose activate inﬂam-
matory mediators in proximal tubular cells in humans.
In addition, functional changes including elevated plasma
creatinine and albuminuria and morphological changes
including fatty inﬁltration and thickening of glomeruli haveInternational Journal of Nephrology 9
Table 3: The eﬀect of fructose feeding on kidney morphology, function, and haemodynamics in rat.
Amount fed Length of
study Eﬀect Reference
60% fructose in diet 4 weeks ↔ Urine volume, ↔ sodium excretion, ↔ creatinin clearance [76]
4w e e k s ↔ Urine volume, ↓ sodium excretion, ↔ RBF, ↔ CBF, ↓ MBF [81]
6m o n t h ↔ Serum creatinine, ↔ BUN [47]
8w e e k s Kidney hypertrophy, glomerular hypertension, cortical
vasoconstriction, arteriolopathy [11]
12 months Glomerular sclerosis, albuminurea, ↑ kidney weight [199]
60 days
↑ Plasma and urine urea level, ↑ plasma and urine uric acid,
↑ plasma and urine creatinine, ↑ plasma and urine albumin and
total protein, fatty inﬁltration, thickening of glomeruli
[200]
30 days ↑ Plasma sodium, ↓ sodium excretion, ↑ urine volume [191]
8w e e k s
↔ GFR; ↔ aﬀerent arteriole resistance; ↔ eﬀerent arteriole
resistance glomerular hypertension, cortical vasoconstriction,
arteriolopathy
[67]
6 weeks Kidney hypertrophy, tubular proliferation, and focal injury [201]
66% fructose in diet 6 weeks ↔ Urine volume, ↔ sodium excretion [192]
8w e e k s ↔ Kidney weight, ↔ RBF, ↔ urine volume, ↔ sodium excretion [156]
65% fructose in diet 4 weeks ↑ Kidney weight, swollen proximal tubular cells [202]
57% fructose in diet 10 weeks ↔ Plasma creatinine, ↑ kidney weight [36]
10% fructose in
drinking water 8w e e k s Kidney hypertrophy, glomerular hypertension, cortical
vasoconstriction, and arteriolopathy [11]
20% fructose in diet 9 weeks ↑ Kidney weight [203]
25% fructose in diet 2 weeks
↑ Creatinine clearance, hyperﬁltration, mesangial cells
proliferation [204]
20% fructose in
drinking water 8w e e k s ↔ Kidney weight, ↔ CBF, ↔ RAP [16]
RBF: Renal Blood Flow, CBF: Cortical Blood Flow, MBF: Medullary Blood Flow, BUN: Blood Urea Nitrogen, GFR: Glomerular Filtration Rate, RAP: Renal
Arterial Pressure. ↑, ↓ and ↔ indicate increase, decrease, and no eﬀect, respectively.
been reported after 60 days of fructose feeding in rat [200].
The renal injury due to fructose-feeding was suggested to
be involved in the increased blood pressure in this model
[22]. On the other hand, altered cardiovascular homeostasis
accompanying kidney damage may also contribute to the
development of hypertension. It has been reported that renal
disturbances associated with fructose-induced metabolic
syndrome become more apparent when higher concentra-
tions of fructose are used [11].
It becomes apparent from these reports that the deteri-
oration in renal haemodynamics and morphology depends
on the prevalence of metabolic syndrome features which, as
indicated earlier, are directly proportional to the amount of
fructose ingested. This view is reinforced by the observations
that consumption of 60% fructose in the diet produces
larger increases in blood pressure, plasma uric acid, and
triglycerides than 10% of fructose in drinking water [11].
Furthermore, the presence of hyperinsulinemia due to
fructose feeding may also play a role in the progression of
renal disease. This view is supported by the observations
that treatment of fructose-fed rats with troglitazone to
correct hyperinsulinemia slowed the progression of renal
disease [209]. Roysommuti et al. [210] have proposed the
hypothesis that a long-term high carbohydrate diet produces
impairment of renal function which is dependent on an
intact renin-angiotensin system. It has been suggested that
the increased urinary NO excretion in high fructose-fed rats
gives an indication of its role in the pathogenesis of the early
renal changes induced by fructose intake [211]. Interestingly,
this study showed that in addition to higher urinary excre-
tion of NO, the one-month fructose-fed rats had glomerular
hypertrophy and increased expression of inducible nitric
oxide synthase enzyme (iNOS) isoform in the kidney. The
role of NO is reinforced by the observation that L-NAME, a
nitric oxide synthase (NOS) enzyme inhibitor, can attenuate
these renal changes [211]. Although hyperinsulinemia has
been suggested as a contributing factor to the pathogenesis
of renal disease in this model, to date the exact mechanisms
responsible for the morphological and functional changes
in the kidney of fructose-fed rat have not been identiﬁed.
Table 3 shows the eﬀect of various routes, amounts, and
lengths of fructose intake on the morphology, function, and
haemodynamics in the kidney of rat.
13. Conclusions
Dietary fructose intake produces hypertension, dyslipide-
mia, insulin resistance and hyperinsulinemia. In addition,
consumption of a high-fructose diet during hyperten-
sion increases mortality and left ventricular wall thickness10 International Journal of Nephrology
compared to either a high fat, high starch, or a “West-
ern” diet [212]. Insulin resistance and hyperinsulinemia
may be responsible for endothelial dysfunction and thereby
participateintheelevatedbloodpressureinthismodel.Most
importantly, over activity of the sympathetic nervous system
due to fructose-feeding has been linked to insulin resistance
and may contribute to the onset and maintenance of cardio-
vascular and renal complications. The intake of increasing
amount of fructose is associated with various manifestations
of metabolic syndrome that consequently lead to derange-
ment of renal morphology and haemodynamics. Thus, it is
evident that adverse eﬀects resulting from fructose ingestion
are concentration and time dependent. Moreover, hyperin-
sulinemia and hypertension contribute signiﬁcantly to the
progressive deterioration in renal function associated with
the metabolic syndrome. Diﬀerent interventions have been
utilizedtocorrecttheabnormalitiesassociatedwithfructose-
induced metabolic syndrome. The use of antioxidants, blood
pressure lowering agents, and other interventions capable of
enhancing insulin sensitivity were found to have beneﬁcial
eﬀects in this model. There is an enigma as to whether
fructose-feeding enhances or decreases or is without eﬀect
on vascular contractile responses. Data to date indicate that
fructose-feeding results in blunted renal vascular response
to adrenergic agonists and Ang II associated with higher
circulating levels of noradrenaline and Ang II. Furthermore,
thereisascarcityofstudiesontheimpactoffructose-feeding
on baroreﬂex control mechanisms and the role played by the
renal sympathetic nerves in regulating kidney function in
this model.
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